Randomized controlled trial of trehalose: An efficient autophagic bioprotectant in the management of dry eye disease

PURPOSE: To compare the therapeutic effect of sodium hyaluronate (SH)–trehalose (Trehalube, Microlabs, Bangalore, India, SH 0.1% and trehalose 3%) or SH (0.1% Hylotears, Raymed, Chandigarh, India) alone in patients with dry eye disease (DED). MATERIALS AND METHODS: Patients were randomized into two...

Descripción completa

Detalles Bibliográficos
Autores principales: Morya, Arvind Kumar, Solanki, Kanchan, Prakash, Sujeet, Samota, Monika, Gupta, Arushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259516/
https://www.ncbi.nlm.nih.gov/pubmed/34295622
http://dx.doi.org/10.4103/tjo.tjo_58_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259516/
https://www.ncbi.nlm.nih.gov/pubmed/34295622
http://dx.doi.org/10.4103/tjo.tjo_58_20

Ejemplares similares